Updates on the Molecular Genetics of Colorectal Cancer
Journal Title: Colorectal Cancer: Open Access - Year 2017, Vol 3, Issue 1
Abstract
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Although definitive therapies for advanced disease are still lacking, rapid progress has been made in the last decade in understanding the molecular mechanisms underlying CRC tumorigenesis and progression. In this review, we summarize the most recent findings in the molecular genetics of CRC with a focus on gene mutations and epigenetic changes that were identified in CRC patients.
Authors and Affiliations
Katherine Wong, Guofeng Xie
Small Intestinal Bacterial Overgrowth following Subtotal Colectomy for Colon Cancer
Background: Increasingly colon cancers are diagnosed early and treated surgically with excellent survival. However, after surgery, one third of patients report chronic unexplained gastrointestinal symptoms and poor quali...
Screening is the Most Effective Preventive Measure against Colorectal Cancer
According to the American Cancer Society, an estimated 135,430 people will be diagnosed with colon cancer in 2017 alone. There’s no denying how much of a problem colorectal cancer has become, but what many people don’t r...
Nicotine Modifies Cytokine Production by Human Mononuclears Stimulated by Colon Cancer Cells
Background: The undesirable effects of prolonged tobacco use and cigarette smoking are well-known and are due to inhalation of a great number of alkaloids including nicotine. Lung cancer is the most feared ailment in chr...
Second Gastric Cancer After the Treatment of Primary Stomach Diffuse Large B-Cell Lymphoma
We report a case of gastric carcinoma occurred 11 years after treatment of gastric lymphoma in a 38-year-old patient with a review of the literature.
Incidence and Clinical Characteristics of Colonic and Extra Colonic Lynch Syndrome Manifestations in Uruguayan Mismatch Repair Carriers
Background: Colon cancer is a frequent diagnosis worldwide affecting both men and women. Lynch syndrome in an autosomal dominant inheritable condition, accountable for 5 to 7% of colon cancer, as well as other malignanci...